CRISPR, Gene Editing & DNA-Repair Antibodies

Evaluate DNA-damage signaling repair-pathway activation and editing outcomes with antibodies targeting  Cas9, RAD51, BRCA2 DNA-PK, ATM, ATR and other key genome-stability proteins.